EmbectavsThermo Fisher Scientific

EMBC and TMO stock compared: price, dividend, valuation and results, from SEC filings.

EMBC

Embecta Corp.

$6.15

Value $360M

-1.60%
EMBC's page

TMO

Thermo Fisher Scientific Inc

$686.79

Value $255B

-0.66%
TMO's page

Embecta (EMBC) has a market value of $360M and Thermo Fisher Scientific (TMO) $255B. Over the last year, with dividends, EMBC moved -56.3% and TMO +19.1%. The P/E is 4.1 for EMBC and 36.1 for TMO. Dividend yield: EMBC 5.20%, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    EMBC$360M

    TMO$255B

    TMO is 709 times EMBC

  • Revenue, 12 months

    EMBC$1.0B

    TMO$47.4B

    TMO is 46 times EMBC

  • Net income, 12 months

    EMBC$88M

    TMO$7.1B

    TMO is 81 times EMBC

  • Operating margin

    EMBC21.9%

    TMO17.9%

    4.0 points apart

  • ROIC

    EMBC20.4%

    TMO8.2%

    12.2 points apart

  • P/E

    EMBC4.1

    TMO36.1

    TMO is 8.8 times EMBC

  • Dividend yield

    EMBC5.2%

    TMO0.3%

    4.9 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

EMBC-58.5%

TMO+48.7%

50100150202420252026
Returns by period
PeriodEMBCWith dividendsTMOWith dividends
1 year since November 14, 2025-56.3%Price -57.7%+19.1%Price +18.7%
3 years since November 17, 2023-58.5%-25.4% a yearPrice -63.0%+48.7%+14.1% a yearPrice +47.2%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

EMBCEmbectaTMOThermo Fisher Scientific

Valuation

EMBCTMO
Valuation
Price$6.15$686.79
Market value$360M$255B
Enterprise value (EV)$1.6B$290B
P/E4.136.1
P/E, 5-year median9.632.7
P/B–4.7
EV/EBIT7.334.3
Free cash flow yield45.7%3.0%

Results and growth

EMBCTMO
Results and growth
Revenue, 12 months$1.0B$47.4B
Net income, 12 months$88M$7.1B
Free cash flow, 12 months$165M$7.6B
Earnings per share, 12 months$1.47$18.96
Revenue growth, year on year-3.8%3.9%
Revenue growth a year, past-0.1%over 5 years+6.7%over 5 years
EPS growth a year, past-26.4%over 5 years+2.1%over 5 years

Margins and returns on capital

EMBCTMO
Margins and returns on capital
Gross margin59.0%–
Operating margin21.9%17.9%
Net margin8.6%14.9%
ROIC20.4%8.2%
ROE–13.4%

Balance sheet

EMBCTMO
Balance sheet
Cash$215M$6.1B
Total debt$1.5B$41.4B
Net debt / EBITDA4.83.7
Interest cover–5.5×

Dividends and buybacks

EMBCTMO
Dividends and buybacks
Dividend yield5.2%0.3%
Dividend per share, 12 months$0.32$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield5.2%1.5%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: EMBC or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Embecta or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($255B) is about 709.0 times Embecta ($360M), at today's prices.

How did EMBC and TMO stock do over the last 3 years?

Since November 17, 2023, EMBC's price moved -63.0% and TMO's +47.2%. With dividends: EMBC -58.5% (-25.4% a year), TMO +48.7% (+14.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, EMBC or TMO?

The dividend yield at today's price is 5.20% for Embecta and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid $0.32 and $1.84 per share.

What is the P/E of EMBC and TMO?

At today's price, the P/E is 4.1 for EMBC and 36.1 for TMO. The median of the last five years was 9.6 and 32.7, which shows where each stands against its own past.

Which has the higher profit margins, Embecta or Thermo Fisher Scientific?

Over the last twelve months, the net margin was 8.6% for Embecta and 14.9% for Thermo Fisher Scientific, and the operating margin 21.9% and 17.9%. Revenue was $1.0B and $47.4B.

Which is the better investment, Embecta or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.